Parameter
| Biomarker | Cu/Zn | Full name | Copper (Cu)/Zinc (Zn) | Molecular Type | Trace Elements |
|---|---|---|---|---|---|
| Molecular Formula | Cu/Zn | Molecular Weight | 63.55/65.38 g/mol | Core Functional Dimensions | Susceptibility, Diagnosis |
| Disease | Schizophrenia | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Hair/Plasma (ICP-MS, PIXE) | ||
| Pathobiological Mechanisms | Elevated copper causes oxidative stress and neurotoxicity; decreased zinc affects neurodevelopment and synaptic function. | ||||
| Clinical Availability Status | Research stage | ||||
| Notes and Dynamics | Characteristic changes of elevated copper and decreased zinc in hair, associated with metabolic parameters. | ||||